Substituted Pyridine Synthesis Without Protecting Groups
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic routes for substituted pyridine compounds are inefficient, resource-intensive, and challenging to scale up due to the use of multiple steps, protecting groups, and chromatographic purifications, which hinder large-scale production and GMP compliance.
Innovation Solution
A method involving sequential reactions with o-tolylmagnesium chloride, N-methylpiperazine, iodine, and 3,5-bis(trifluoromethyl)benzyl bromide, along with the formation of a dihydrochloride salt, allows for the synthesis of substituted pyridine compounds in high yields and kilogram-scale quantities, minimizing the use of protecting groups and avoiding high or low temperatures, and employing simple purification methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multiple synthetic steps with protecting groups and chromatographic purifications are used, then the synthesis can achieve the target substituted pyridine compounds, but the overall efficiency and atom economy are reduced
Solution Approach 1:
The invention removes protecting groups from the synthetic route entirely. The patent describes a direct synthesis method where the pyridine compound is formed without requiring temporary protective groups on functional groups, thereby eliminating the steps of installation and removal of protecting groups, improving both efficiency and atom economy
Solution Approach 2:
The invention performs the pyridine ring formation and substitution reactions in a optimized sequence that prevents the need for subsequent purification by chromatography. The reaction conditions are designed to directly produce the target compound with sufficient purity for large-scale manufacturing
2Manufacturing precision
If chromatographic purification procedures are used for compounds and intermediates, then the purity can be achieved, but the process becomes time- and resource-consuming
Solution Approach 1:
The invention employs reaction conditions and sequences that maintain product purity throughout the synthesis without requiring intermediate isolation and chromatographic purification. The continuous flow of reaction steps produces the final compound directly in a form suitable for large-scale manufacturing
Solution Approach 2:
The invention replaces expensive and time-consuming chromatographic purification with simpler, more economical purification methods such as filtration and washing that are suitable for large-scale production
3Quantity of substance
If the synthesis is performed on milligram or gram scale with moderate yields, then the target compound can be produced, but it is challenging to scale up to larger quantities
Solution Approach 1:
The invention optimizes reaction parameters including temperature, solvent selection, reagent ratios, and reaction time to enable scaling from small to large scale. The patent describes conditions that maintain high yields and product quality regardless of scale, making the process suitable for kilogram-scale production
Solution Approach 2:
The invention develops a synthetic route that can be applied universally across different scales of production. The same reaction conditions and procedures described in the patent can be used whether producing milligrams for research or kilograms for commercial manufacturing
4Manufacturing precision
If very high (130° C.) or very low (−78° C.) temperatures are used in reactions, then the desired chemical transformations can occur, but the process becomes less suitable for large-scale production
Solution Approach 1:
The invention modifies reaction temperature parameters to avoid extreme conditions. The patent describes reactions conducted at moderate temperatures that are safer and more practical for large-scale production while still achieving the desired chemical transformations and product purity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables efficient, scalable production of substituted pyridine compounds suitable for medical administration, with improved processing and therapeutic advantages, particularly for intravenous formulations, by reducing the need for isolation steps and using safer, more efficient reaction conditions.
Implementation Method 1
treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine
Implementation Method 2
treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine
Implementation Method 3
treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine
Implementation Method 4
treating the compound of Formula (3) from step a) with 3,5-bis(trifluoromethyl)benzyl bromide and a suitable base
Implementation Method 5
treating the compound of Formula (1) obtained from step b) with a solution of hydrochloric acid in diethyl ether
Data Source
AI summary
There is disclosed a method of preparing a compound of Formula (1), or a salt thereof (1) the method comprising: a) treating a compound of Formula (2) sequentially with o-tolylmagnesium chloride, N-methylpiperazine and iodine, under conditions sufficient to obtain a compound of Formula (3) b) treating the compound of Formula (3) from step a) with 3,5-bis(trifluoromethyl)benzyl bromide and a suitable base, under conditions sufficient to obtain a compound of Formula (1).